Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW
Conditions: Hiv; Prophylaxis; Transgender Interventions: Drug: Truvada alone; Drug: Truvada plus Leuprolide; Drug: Truvada plus Estradiol 1 mg; Drug: Truvada plus Estradiol 6 mg; Drug: Estradiol 6 mg alone Sponsors: Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Hormonal Therapy | Hormones | Infectious Diseases | Research